trial · primary record
Nerandomilast
Fibrosing Interstitial Lung Disease
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 35 |
| Primary completion | 2031-04-14 |
| Primary endpoint | Area under the concentration curve (AUC) T,SS based on sampling at steady state using rich sampling in participants from 6 years to less than 18 years and sparse sampling in participants younger than 6 years |
| Registry ID | NCT07366034 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:38.656Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07366034
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.